Axon price target raised to $585 from $387 at Barclays

Barclays raised the firm’s price target on Axon (AXON) to $585 from $387 and keeps an Overweight rating on the shares. The firm says Axon’s strength continued with Q3 revenue up 32%, the third quarter this fiscal year above 30%. The company’s Q3 saw strength across the board with Taser performance a notable standout, the analyst tells investors in a research note. Barclays does not view the Taser outperformance as pull-in demand for the T10, but more so the company’s ability to ship existing capacity coupled with strength in some of the older models.